Liisa A Saarikoski1,2, Markus Juonala3, Risto Huupponen4, Jorma S A Viikari3, Terho Lehtimäki5, Eero Jokinen6, Nina Hutri-Kähönen7, Leena Taittonen8,9, Tomi Laitinen10, Olli T Raitakari1,11. 1. a Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku , Turku , Finland. 2. b Department of Pediatrics , University of Turku and Turku University Hospital , Turku , Finland. 3. c Department of Medicine , University of Turku and Division of Medicine, Turku University Hospital , Turku , Finland. 4. d Department of Pharmacology, Drug Development and Therapeutics , University of Turku, and Unit of Clinical Pharmacology, Turku University Hospital , Turku , Finland. 5. e Department of Clinical Chemistry , Fimlab Laboratories and School of Medicine, University of Tampere , Tampere , Finland. 6. f Department of Pediatric Cardiology, Hospital for Children and Adolescents and Department of Pediatrics , University of Helsinki , Helsinki , Finland. 7. g Department of Pediatrics , University of Tampere and Tampere University Hospital , Tampere , Finland. 8. h Department of Pediatrics , Vaasa Central Hospital , Vaasa , Finland. 9. i Department of Pediatrics , University of Oulu , Oulu , Finland. 10. j Department of Clinical Physiology , University of Eastern Finland and Kuopio University Hospital , Kuopio , Finland. 11. k Department of Clinical Physiology and Nuclear Medicine , Turku University Hospital , Turku , Finland.
Abstract
INTRODUCTION: Low adiponectin levels may predict the development of atherosclerosis. We examined the association of childhood adiponectin with preclinical carotid atherosclerosis that is defined as plaque and/or high (≥95th percentile) intima-media thickness (IMT) at the carotid bifurcation in adulthood. METHODS: The Cardiovascular Risk in Young Finns Study is a cohort study on cardiovascular risk factors. We used risk factor data from the baseline study (1980) and ultrasound findings from the follow-ups (2001 and 2007). The study population included 1708 participants, aged 3-18 years at baseline. RESULTS: In multivariate analysis, childhood adiponectin was inversely associated with preclinical carotid atherosclerosis: odds ratio 0.68, 95% confidence interval (CI) 0.53-0.86, p = .001, for 1-SD increase in childhood adiponectin after adjusting for childhood non-high-density lipoprotein cholesterol, body mass index, and blood pressure. When examining the incremental predictive ability, we observed that compared to an approach utilizing only conventional risk factors, the model additionally including adiponectin levels improved c-statistics area under curve from 0.733 (95% Cl 0.694-0.771) to 0.748 (95% Cl 0.710-0.786), p = .02. CONCLUSIONS: Childhood adiponectin levels improve the prediction of carotid atherosclerosis in adulthood over conventional risk factors. This supports the idea that low adiponectin levels may have a role in the development of preclinical atherosclerosis. Key messages Childhood adiponectin levels improve the prediction of increased carotid intima-media thickness in adulthood over conventional cardiovascular risk factors. These results suggest that adiponectin levels measured in childhood may have a role in the atherosclerotic process.
INTRODUCTION: Low adiponectin levels may predict the development of atherosclerosis. We examined the association of childhood adiponectin with preclinical carotid atherosclerosis that is defined as plaque and/or high (≥95th percentile) intima-media thickness (IMT) at the carotid bifurcation in adulthood. METHODS: The Cardiovascular Risk in Young Finns Study is a cohort study on cardiovascular risk factors. We used risk factor data from the baseline study (1980) and ultrasound findings from the follow-ups (2001 and 2007). The study population included 1708 participants, aged 3-18 years at baseline. RESULTS: In multivariate analysis, childhood adiponectin was inversely associated with preclinical carotid atherosclerosis: odds ratio 0.68, 95% confidence interval (CI) 0.53-0.86, p = .001, for 1-SD increase in childhood adiponectin after adjusting for childhood non-high-density lipoprotein cholesterol, body mass index, and blood pressure. When examining the incremental predictive ability, we observed that compared to an approach utilizing only conventional risk factors, the model additionally including adiponectin levels improved c-statistics area under curve from 0.733 (95% Cl 0.694-0.771) to 0.748 (95% Cl 0.710-0.786), p = .02. CONCLUSIONS: Childhood adiponectin levels improve the prediction of carotid atherosclerosis in adulthood over conventional risk factors. This supports the idea that low adiponectin levels may have a role in the development of preclinical atherosclerosis. Key messages Childhood adiponectin levels improve the prediction of increased carotid intima-media thickness in adulthood over conventional cardiovascular risk factors. These results suggest that adiponectin levels measured in childhood may have a role in the atherosclerotic process.
Authors: Yang Du; Tao Zhang; Dianjianyi Sun; Changwei Li; Lydia Bazzano; Lu Qi; Marie Krousel-Wood; Jiang He; Paul K Whelton; Wei Chen; Shengxu Li Journal: Am J Cardiol Date: 2017-12-12 Impact factor: 2.778
Authors: Laura Kananen; Mikko Hurme; Alexander Bürkle; Maria Moreno-Villanueva; Jürgen Bernhardt; Florence Debacq-Chainiaux; Beatrix Grubeck-Loebenstein; Marco Malavolta; Andrea Basso; Francesco Piacenza; Sebastiano Collino; Efstathios S Gonos; Ewa Sikora; Daniela Gradinaru; Eugene H J M Jansen; Martijn E T Dollé; Michel Salmon; Wolfgang Stuetz; Daniela Weber; Tilman Grune; Nicolle Breusing; Andreas Simm; Miriam Capri; Claudio Franceschi; Eline Slagboom; Duncan Talbot; Claude Libert; Jani Raitanen; Seppo Koskinen; Tommi Härkänen; Sari Stenholm; Mika Ala-Korpela; Terho Lehtimäki; Olli T Raitakari; Olavi Ukkola; Mika Kähönen; Marja Jylhä; Juulia Jylhävä Journal: Geroscience Date: 2022-07-21 Impact factor: 7.581